drug

umeclidinium

1 story · latest Jul 6, 2026

Status: FDA approved Apr 2014 · NDA205382
Brands: Incruse Ellipta, Umeclidinium Ellipta

Relationships

Developed by GlaxoSmithKline

Timeline

Vicore Pharma names Rob Slack chief scientific officer

Jul 6Peoplebuloxibutid Vicore Pharma AB

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.